Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 77.

Hurt, Christopher, Morgan, Meleri, Williams, Namor, Phillips, Ceri J., Williams, Geraint T., Gardner, Georgina, Porter, Catherine, Sampson, Julian, Hillier, Sharon, Heard, Hayley and Dolwani, Sunil 2019. Feasibility and economic evaluation of chromocolonoscopy for detection of proximal serrated neoplasia: a randomised controlled trial within a population based colorectal cancer screening programme (the CONSCOP study): an open-label, randomised controlled non-inferiority trial. Lancet Gastroenterology and Hepatology 4 (5) , pp. 364-375. 10.1016/S2468-1253(19)30035-4
file

Strauss, Victoria Y., Shaw, Rachel, Virdee, Pradeep S., Hurt, Christopher N., Ward, Elizabeth, Tranter, Bethan, Patel, Neel, Bridgewater, John, Parsons, Philip, Radhakrishna, Ganesh, O'Neill, Eric, Sebag-Montefiore, David, Hawkins, Maria, Corrie, Pippa G., Maughan, Timothy and Mukherjee, Somnath 2019. Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer 19 (1) , 121. 10.1186/s12885-019-5307-z
file

Gollins, Simon, West, Nicholas, Sebag-Montefiore, David, Susnerwala, Shabbir, Falk, Stephen, Brown, Nick, Saunders, Mark, Quirke, Philip, Ray, Ruby, Parsons, Philip, Griffiths, Gareth, Maughan, Tim, Adams, Richard and Hurt, Christopher 2018. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer 10.1038/s41416-018-0209-4
file

Prout, Hayley C., Barham, Allan, Bongard, Emily, Tudor-Edwards, Rhiannon, Griffiths, Gareth, Hamilton, Willie, Harrop, Emily, Hood, Kerenza, Hurt, Christopher N., Nelson, Rosi, Porter, Catharine, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Rachel Emma, Tod, Angela, Yeo, Seow Tien, Neal, Richard D. and Nelson, Annmarie 2018. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials 19 , 419. 10.1186/s13063-018-2803-4
file

Hurt, Christopher N., Jones, Sadie E. F., Madden, Tracie-Ann, Fiander, Alison, Nordin, Andrew J., Naik, Raj, Powell, Ned, Carucci, Margherita and Tristram, Amanda 2018. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multi-centre, randomised, phase II trial (RT3VIN). BJOG: An International Journal of Obstetrics and Gynaecology 125 (9) , pp. 1171-1177. 10.1111/1471-0528.15124
file

Holyoake, D.L.P., Warren, D.R., Hurt, Chris N., Aznar, M., Partridge, M., Mukherjee, S. and Hawkins, M.A. 2018. Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer. Clinical Oncology 30 (7) , pp. 418-426. 10.1016/j.clon.2018.02.067
file

Alderdice, Matthew, Richman, Susan D, Gollins, Simon, Stewart, Peter, Hurt, Christopher, Adams, Richard, McCorry, Amy, Roddy, Aideen, Vimalachandran, Dale, Isella, Claudio, Medico, Enzo, Maughan, Tim, McArt, Darragh G, Lawler, Mark and Dunne, Philip D 2018. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies. The Journal of Pathology 245 (1) , pp. 19-28. 10.1002/path.5051
file

Warren, Samantha, Hurt, Christopher N., Crosby, Thomas, Partridge, Mike and Hawkins, Maria A. 2017. Potential of proton therapy to reduce acute hematologic toxicity in concurrent chemoradiation therapy for esophageal cancer. International Journal of Radiation Oncology - Biology - Physics 99 (3) , pp. 729-737. 10.1016/j.ijrobp.2017.07.025
file

Holyoake, D. L., Partridge, M., Hurt, Christopher, Mukherjee, S. and Hawkins, M. A. 2017. Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy. International Journal of Radiation Oncology - Biology - Physics 99 (2) , E155. 10.1016/j.ijrobp.2017.06.971

Cox, Samantha, Hurt, Christopher, Grenader, Tal, Mukherjee, Somnath, Bridgewater, John and Crosby, Thomas 2017. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiotherapy and Oncology 125 (1) , pp. 154-159. 10.1016/j.radonc.2017.08.023
file

Jones, Sadie, Hibbitts, Samantha Jayne, Hurt, Chris Nicholas, Bryant, Dean, Fiander, Alison Nina, Powell, Ned George and Tristram, Amanda 2017. Human Papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in Vulval Intraepithelial Neoplasia 3. Clinical Cancer Research 23 (18) , pp. 5460-5468. 10.1158/1078-0432.CCR-17-0040
file

Mukherjee, Somnath, Hurt, Christopher Nicholas and Crosby, Tom 2017. Response to: Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen. European Journal of Cancer 83 , pp. 333-334. 10.1016/j.ejca.2017.06.040

Hurt, Chris Nicholas, Falk, S., Crosby, T., McDonald, A., Ray, R., Joseph, G., Staffurth, John Nicholas, Abrams, R. A., Griffiths, G., Maughan, T. and Mukherjee, S. 2017. Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. British Journal of Cancer 116 (10) , pp. 1264-1270. 10.1038/bjc.2017.95
file

Crosby, Tom, Hurt, Christopher, Falk, S, Gollins, S, Staffurth, John, Ray, Ruby, Bridgewater, J A, Geh, J I, Cunningham, D, Blazeby, J, Roy, R, Maughan, Timothy, Griffiths, Gwyn and Mukherjee, Saptarshi 2017. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/? cetuximab in oesophageal cancer. British Journal of Cancer 116 (6) , pp. 709-716. 10.1038/bjc.2017.21
file

Gillespie, David, Farewell, Daniel, Barrett-Lee, Peter, Casbard, Angela, Hawthorne, Anthony Barney, Hurt, Christopher, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza 2017. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 18 (1) , 117. 10.1186/s13063-017-1837-3
file

Mukherjee, Somnath, Hurt, Christopher Nicholas, Gwynne, Sarah, Sebag-Montefiore, David, Radhakrishna, Ganesh, Gollins, Simon, Hawkins, Maria, Grabsch, Heike I., Jones, Gareth, Falk, Stephen, Sharma, Ricky, Bateman, Andrew, Roy, Rajarshi, Ray, Ruby, Canham, Joanna, Griffiths, Gareth, Maughan, Tim and Crosby, Tom 2017. NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer 74 , pp. 38-46. 10.1016/j.ejca.2016.11.031
file

Neal, Richard D, Barham, Allan, Bongard, Emily, Tudor Edwards, Rhiannon, Fitzgibbon, Jim, Griffiths, Gareth, Hamilton, Willie, Hood, Kerenza, Nelson, Annmarie, Parker, David, Porter, Catharine, Prout, Hayley, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Emma, Tod, Angela, Yeo, Seow Tien and Hurt, Christopher 2017. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer 116 (3) , pp. 293-302. 10.1038/bjc.2016.414
file

Fokas, Emmanouil, Spezi, Emiliano, Patel, Neel, Hurt, Chris Nicholas, Nixon, Lisette Sheena, Chu, Kwun-Ye, Staffurth, John Nicholas, Abrams, Ross and Mukherjee, Somnath 2016. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial. Radiotherapy and Oncology 120 (2) , pp. 212-216. 10.1016/j.radonc.2016.07.002
file

Cox, S., Powell, C., Carter, Ben Richard, Hurt, Chris Nicholas, Mukherjee, Somnath and Crosby, Thomas 2016. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. British Journal of Cancer 2016 (115) , pp. 172-177. 10.1038/bjc.2016.129
file

Fokas, E., Spezi, Emiliano, Patel, N., Hurt, Chris Nicholas, Nixon, Lisette Sheena, Chu, K., Joseph, G., Staffurth, John Nicholas, Abrams, R. and Mukherjee, S. 2016. P-222 Analysis of tumour contours and radiotherapy planning of "on-trial" patients undergoing chemoradiotherapy (CRT) in SCALOP trial: does pre-trial Radiotherapy Quality Assurance (RTQA) improve the quality of "on-trial" radiotherapy? Annals of Oncology 27 (suppl) , ii64.3-ii65.. 10.1093/annonc/mdw199.214
file

O'Leary, Maureen, Thomas, Sara, Hurt, Lisa, Floyd, Sian, Shannon, Caitlin, Newton, Sam, Thomas, Gyan, Amenga-Etego, Seeba, Tawiah-Agyemang, Charlotte, Gram, Lu, Hurt, Chris Nicholas, Bahl, Rajiv, Owusu-Agyei, Seth, Kirkwood, Betty and Edmond, Karen 2016. Vaccination timing of low-birth-weight infants in rural Ghana: a population-based, prospective cohort study. Bulletin of the World Health Organization 94 (6) , 442-451D. 10.2471/BLT.15.159699

Hurt, Christopher 2016. An analysis of plan robustness for Esophageal tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning. International Journal of Radiation Oncology*Biology*Physics 95 (1) , pp. 199-207. 10.1016/j.ijrobp.2016.01.044
file

Carrington, R., Spezi, Emiliano, Gwynne, S., Dutton, P., Hurt, Chris Nicholas, Staffurth, John Nicholas and Crosby, T. 2016. The influence of radiotherapy treatment method on dose distribution and its relation to patient outcome in the SCOPE 1 oesophageal cancer trial using Type B algorithms. BMC Medical Physics 42 (6) , p. 3703. 10.1186/s13014-016-0594-x
file

Carrington, Rhys, Spezi, Emiliano, Gwynne, Sarah, Dutton, Peter, Hurt, Chris Nicholas, Staffurth, John Nicholas and Crosby, Thomas 2016. The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial. Radiation Oncology 11 (19) , pp. 1-8. 10.1186/s13014-016-0594-x
file

Mukherjee, Somnath, Hurt, Chris, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Radhakrishna, Ganesh, Canham, Jo, Ray, Ruby, Grabsch, Heike I, Sharma, Ricky A., Maggs, Rhydian, Hawkins, Maria A, Sebag-Montefiore, David, Maughan, Tim, Griffiths, Gareth and Crosby, Tom David Lewis 2016. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma. Journal of Clinical Oncology 34 (4_supp) , p. 3. 10.1200/jco.2016.34.4_suppl.3

Fokas, Emmanouil, Clifford, Charlotte, Spezi, Emiliano, Joseph, George, Branagan, Jennifer, Hurt, Chris Nicholas, Nixon, Lisette Sheena, Abrams, Ross, Staffurth, John Nicholas and Mukherjee, Somnath 2015. Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial. Radiotherapy and Oncology 117 (3) , pp. 432-437. 10.1016/j.radonc.2015.08.026
filefile

Carrington, Rhys, Staffurth, John Nicholas, Warren, Samantha, Partridge, Mike, Hurt, Chris Nicholas, Spezi, Emiliano, Gwynne, Sarah, Hawkins, Maria A. and Crosby, Thomas 2015. The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation. Radiation Oncology 10 , 236. 10.1186/s13014-015-0537-y
file

Gillespie, David, Hood, Kerenza, Farewell, Daniel, Hawthorne, Antony, Hurt, Chris Nicholas, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter, Casbard, Angela C. and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129
file

Hurt, Chris Nicholas, Mukherjee, Somnath, Bridgewater, John, Falk, Stephen, Crosby, Tom, McDonald, Alec, Joseph, George, Staffurth, John Nicholas, Abrams, Ross A., Blazeby, Jane M., Bridges, Sarah, Dutton, Peter, Griffiths, Gareth, Maughan, Timothy and Johnson, Colin 2015. Health-related quality of life in SCALOP, a randomized Phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer. International Journal of Radiation Oncology Biology Physics 93 (4) , pp. 810-818.
file

Hurt, Chris Nicholas, Mukherjee, Somnath, Bridgewater, John, Falk, Stephen, Crosby, Tom, McDonald, Alec, Joseph, George, Staffurth, John Nicholas, Abrams, Ross A., Blazeby, Jane M., Bridges, Sarah, Dutton, Peter, Griffiths, Gareth, Maughan, Tim and Johnson, Colin 2015. Health related quality of life in SCALOP, a randomized phase II trial comparing chemoradiotherapy regimens in locally advanced pancreatic cancer (LAPC). International Journal of Radiation Oncology*Biology*Physics 93 (4) , pp. 810-818. 10.1016/j.ijrobp.2015.08.026
file

Owadally, Waheeda, Hurt, Chris, Timmins, Hayley, Parsons, Emma, Townsend, Sarah, Patterson, Joanne, Hutcheson, Katherine, Powell, Ned, Beasley, Matthew, Palaniappan, Nachi, Robinson, Max, Jones, Terence M. and Evans, Mererid 2015. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer 15 , 602. 10.1186/s12885-015-1598-x
file

Rees, J., Hurt, Chris Nicholas, Gollins, S., Mukherjee, S., Maughan, Timothy, Falk, S. J., Staffurth, John Nicholas, Ray, Ruby, Bashir Mohamad, Nurul, Geh, J. I., Cunningham, D., Roy, R., Bridgewater, J., Griffiths, G., Nixon, Lisette Sheena, Blazeby, J. M. and Crosby, T. 2015. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer 113 (4) , pp. 603-610. 10.1038/bjc.2015.258

Gollins, Simon, Sebag-Montefiore, David, Adams, Richard, Saunders, Mark P., Grieve, Robert, Scott, Nigel, Brown, Gina, Quirke, Philip, Butlin, Laura, Ray, Ruby, Griffiths, Gareth and Hurt, Chris Nicholas 2015. A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). Journal of Clinical Oncology 33 (15) , p. 3609.

Edmond, Karen M, Newton, Sam, Shannon, Caitlin, O'Leary, Maureen, Hurt, Lisa, Thomas, Gyan, Amenga-Etego, Seeba, Tawiah-Agyemang, Charlotte, Gram, Lu, Hurt, Chris Nicholas, Bahl, Rajiv, Owusu-Agyei, Seth and Kirkwood, Betty R 2015. Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial. The Lancet 385 (9975) , pp. 1315-1323. 10.1016/S0140-6736(14)60880-1

Mukherjee, Somnath, Hurt, Chris Nicholas, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Radhakrishna, Ganesh, Hawkins, Maria, Canham, Joanna, Lewis, Wyn, Grabsch, Heike I, Sharma, Ricky A, Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Sebag-Montefiore, David, Maughan, Timothy, Griffiths, Gareth and Crosby, Tom 2015. NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer 15 (1) , 48. 10.1186/s12885-015-1062-y

Tristram, Amanda Jane, Hurt, Christopher Nicholas, Madden, Tracie-Ann, Powell, Ned George, Man, Stephen Tzekwung, Hibbitts, Samantha Jayne, Dutton, Peter, Jones, Sadie, Nordin, Andrew J., Naik, Raj, Fiander, Alison Nina and Griffiths, Gareth 2014. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology 15 (12) , pp. 1361-1368. 10.1016/S1470-2045(14)70456-5
file

Adamson, Douglas, Blazeby, Jane, Nelson, Annmarie, Hurt, Chris Nicholas, Nixon, Lisette Sheena, Fitzgibbon, Jim, Crosby, Tom, Staffurth, John Nicholas, Evans, Mim, Kelly, Noreen, Cohen, David, Griffiths, Gareth and Byrne, Anthony 2014. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial. Trials 15 , 402. 10.1186/1745-6215-15-402
file

Warren, Samantha, Partridge, Mike, Carrington, Rhys, Hurt, Chris Nicholas, Crosby, Thomas and Hawkins, Maria A. 2014. Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 90 (2) , pp. 423-429. 10.1016/j.ijrobp.2014.06.028

Mukherjee, Somnath, Hurt, Chris Nicholas, Dutton, Peter, Bridgewater, John A., Crosby, Thomas, Mcdonald, Alec, Falk, Stephen, Abrams, Ross A., Maughan, Timothy Stanley and Griffiths, Gareth 2014. Impact of gemcitabine (Gem)-or capecitabine (Cape)-based chemoradiation (CRT) on health-relatedquality of life (HRQL) in patients with locally advanced pancreatic cancer (LAPC): Outcomes from the randomized phase II SCALOP trial [Abstract]. Journal of Clinical Oncology 32 (5) , 4126. 10.1200/jco.2014.32.15_suppl.4126

Crosby, Thomas, Mukherjee, Somnath, Hurt, Chris Nicholas, Gwynne, Sarah, Gollins, Simon, Batrman, Andrew Rea, Lewis, Wyn Griffith, Radhakrishna, Ganesh, Hawkins, Maria, Grabsch, Heike I., Ray, Ruby, Sharma, Ricky A., Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Hadlow, Sue, Sebag-Montefiore, David, Maughan, Tim and Griffiths, Gareth 2014. NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer [Abstract]. Journal of Clinical Oncology 32 (15_sup) , TPS4144. 10.1200/jco.2014.32.15_suppl.tps4144

Huggett, Matthew T., Passant, Helen, Hurt, Chris Nicholas, Pereira, Stephen P., Bridgewater, John and Mukherjee, Somnath 2014. Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United Kingdom. Tumori 100 (2) , pp. 219-224. 10.1700/1491.16421

Neal, R. D., Hurt, Chris Nicholas, Roberts, K., Rogers, T., Hamilton, W., Tudor Edwards, R., Tod, A. M., Parker, D., Thomas Jones, E., Nelson, Annmarie, Prout, H., Hood, Kerenza and Griffiths, G. 2014. A feasibility randomised controlled trial looking at the effect on lung cancer diagnosis of giving a chest X-ray to smokers aged over 60 with new chest symptoms – the ELCID trial [Abstract]. Lung Cancer 83 , S81-S82. 10.1016/S0169-5002(14)70220-X

Prout, Hayley, Neal, Richard, Roberts, Kirsty, Hurt, Chris, Rogers, Trevor, Hamilton, Willie, Edwards, Rhiannon, Todd, Angela, Parker, David, Jones, Emma, Hood, Kerenza, Griffiths, Gareth, Barham, Allan, Fitzgibbon, Jim and Nelson, Annmarie 2013. ELCID: early lung cancer identification and diagnosis - an embedded interview study to explore patient participation and recruitment. Trials 14 (S1) , P102. 10.1186/1745-6215-14-S1-P102
file

Nixon, Lisette Sheena, Mukherjee, S., Wills, L., Millin, T., Bridges, Sarah, Abrams, R. A., Joseph, G., Griffiths, G., Hurt, Chris Nicholas and Staffurth, John Nicholas 2013. The SCALOP Trial Plan Assessment Form (PAF) as a tool for Radiation Therapy Trials Quality Assurance (RTTQA). International Journal of Radiation Oncology*Biology*Physics 87 (2) , S306. 10.1016/j.ijrobp.2013.06.804

Crosby, Thomas David Lewis, Hurt, Chris Nicholas, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John Nicholas, Ray, Ruby, Bashir, Nadim, Bridgewater, John A., Geh, J. Ian, Cunningham, David, Blazeby, Jane, Roy, Rajarshi, Maughan, Timothy Stanley and Griffiths, Gareth O. 2013. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology 14 (7) , pp. 627-637. 10.1016/S1470-2045(13)70136-0
file

Danso, S., Atwell, E., Johnson, O., ten Asbroek, G., Soremekun, S., Edmond, K., Hurt, Chris Nicholas, Hurt, Lisa, Zandoh, C., Tawiah, C., Hill, Z., Fenty, J., Amenga Etego, S., Owusu Agyei, S. and Kirkwood, B. R. 2013. A semantically annotated corpus for automatic verbal autopsy analysis. International Computer Archive Of Modern English 37 , pp. 67-100.

Mukherjee, Somnath, Hurt, Chris Nicholas, Bridgewater, John, Falk, Stephen, Cummins, Sebastian, Wasan, Harpreet, Crosby, Thomas David Lewis, Jephcott, Catherine, Roy, Rajarshi, Radhakrishna, Ganesh, McDonald, Alec, Ray, Ruby, Joseph, George, Staffurth, John Nicholas, Abrams, Ross A., Griffiths, Gareth O. and Maughan, Timothy Stanley 2013. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology 14 (4) , pp. 317-326. 10.1016/S1470-2045(13)70021-4
file

Branagan, J. M. R., Halle, C., Falk, S., Radhakrishna, G., Roy, R., Crosby, T., Hurt, Chris Nicholas, Brunner, T. B. and Mukherjee, S. 2013. Reduction of interobserver variability (IOV) by FDG-PET-based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer. Journal of Clinical Oncology 31 (4)

Crosby, T., Hurt, Chris Nicholas, Falk, S., Gollins, S., Mukherjee, Saptarshi, Staffurth, John Nicholas, Ray, Ruby, Bashir, N., Bridgwater, J., Geh, J. I., Cunningham, D., Blazeby, J., Roy, R., Maughan, T and Griffiths, Gareth 2013. SCOPE 1: A phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. American Journal of Clinical Oncology 31 (Supp 4) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

Mukherjee, S., Hurt, Chris Nicholas, Griffiths, G., Bridgewater, J. A., Crosby, T., Falk, S., Cummins, S., Roy, R., Mangar, S., Mcdonald, A., Staffurth, John Nicholas, Abrams, R. A. and Maughan, T. 2013. SCALOP: Results of a randomized phase II study of induction chemotherapy followed by genicitabine (G) or capecitabine (Cap) based chentoradialion (CRT) in locally advanced pancreatic cancer (LANPC). American Journal of Clinical Oncology 31 (Supp 4)

Mukherjee, Somnath, Halle, Charlotte, Spezi, Emiliano, Joseph, George, Mary, Jennifer, Branagan, Rose, Hurt, Chris Nicholas, Falk, Stephen, Nixon, Lisette Sheena, Abrams, Ross A. and Staffurth, John Nicholas 2013. Comparison of investigator-delineated GTV in chemoradiotherapy (CRT) for locally advanced nonmetastatic pancreatic cancer (LANPC): Analysis of the pretrial test case for the SCALOP trial. Journal of Clinical Oncology 31 (4) , 230.

Hurt, Lisa, ten Asbroek, Augustinus, Amenga-Etego, Seeba, Zandoh, Charles, Danso, Samuel, Edmond, Karen, Hurt, Chris Nicholas, Tawiah, Charlotte, Hill, Zelee, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona M. and Kirkwood, Betty R. 2013. Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial. Bulletin of the World Health Organization 91 (1) , pp. 19-27. 10.2471/BLT.11.100412

Hurt, Chris Nicholas, Roberts, Kirsty, Rogers, Trevor K, Griffiths, Gareth O., Hood, Kerenza, Prout, Hayley Christine, Nelson, Annmarie, Fitzgibbon, Jim, Barham, Allan, Thomas-Jones, Emma, Edwards, Rhiannon, Yeo, Seow, Hamilton, William, Tod, Angela and Neal, Richard D 2013. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials 14 (1) , 405. 10.1186/1745-6215-14-405
file

Crosby, Thomas, Hurt, Chris, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John, Ray, Ruby, Bridgewater, John A., Geh, Ian, Cunningham, David, Maughan, Tim and Griffiths, Gareth 2013. SCOPE 1: a phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. Journal of Clinical Oncology 31 (4_supp) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

Gwynne, Sarah Helene, Spezi, Emiliano, Wills, Lucy, Nixon, Lisette Sheena, Hurt, Chris Nicholas, Joseph, George, Evans, Mererid, Griffiths, Gareth O., Crosby, Thomas David Lewis and Staffurth, John Nicholas 2012. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. International Journal of Radiation Oncology*Biology*Physics 84 (4) , pp. 1037-1042. 10.1016/j.ijrobp.2012.01.094

Hendry, Maggie, Pasterfield, Diana, Lewis, Robert, Clements, A., Damery, S., Neal, Richard D., Adke, R., Weller, D., Campbell, C., Patnick, J., Sasieni, P., Hurt, Chris Nicholas, Wilson, S. and Wilkinson, Clare Elizabeth 2012. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. British Journal of Cancer 107 (2) , pp. 243-254. 10.1038/bjc.2012.256

Edmond, Karen, Hurt, Lisa, Fenty, Justin, Amenga-Etego, Seeba, Zandoh, Charles, Hurt, Chris Nicholas, Danso, Samuel, Tawiah, Charlotte, Hill, Zelee, ten Asbroek, Augustinus H. A., Owusu-Agyei, Seth, Campbell, Oona and Kirkwood, Betty R. 2012. Effect of vitamin A supplementation in women of reproductive age on cause-specific early and late infant mortality in rural Ghana: ObaapaVitA double-blind, cluster-randomised, placebo-controlled trial. British Medical Journal Open 2 (1) , e000658. 10.1136/bmjopen-2011-000658
file

Hurt, Christopher Nicholas, Nixon, Lisette Sheena, Griffiths, Gareth O., Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N., Phillips, Ceri J., Blazeby, Jane M. and Crosby, Tom D. 2011. SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer 11 (1) , p. 466. 10.1186/1471-2407-11-466

Gwynne, S., Spezi, Emiliano, Staffurth, John Nicholas, Palaniappan, N., Wills, L., Hurt, Chris Nicholas, Nixon, Lisette Sheena, Evans, M., Griffiths, G. and Crosby, T. 2011. Inter-observer variation in outlining of pre-trial test case in the SCOPE1 trial: A United Kingdom definitive chemoradiotherapy trial for esophageal cancer. International Journal of Radiation Oncology - Biology - Physics 81 (2) , S67-S68. 10.1016/j.ijrobp.2011.06.135

Gwynne, Sarah Helene, Hurt, Chris Nicholas, Evans, M., Holden, C., Vout, Lauren and Crosby, Thomas David Lewis 2011. Definitive Chemoradiation for Oesophageal Cancer - A Standard of Care in Patients with Non-metastatic Oesophageal Cancer. Clinical Oncology 23 (3) , pp. 182-188. 10.1016/j.clon.2010.12.001

Hurt, Chris Nicholas and SEARCH Collaborative Group, 2010. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. The Lancet 376 (9753) , pp. 1658-1669. 10.1016/S0140-6736(10)60310-8

Mukherjee, S., Hurt, Chris Nicholas, Griffiths, G., Crosby, T. S., Staffurth, John Nicholas, Bridges, Sarah, Bridgewater, J. A., Mcdonald, A., Falk, S. and Maughan, Timothy Stanley 2010. A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer. American Journal of Clinical Oncology 28

Hudson, E., Hurt, Chris Nicholas, Mort, D., Brewster, A. E., Iqbal, N., Joseph, George, Crosby, Thomas David Lewis and Mukherjee, Saptarshi 2010. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment. Clinical Oncology 22 (1) , pp. 27-35. 10.1016/j.clon.2009.09.024

Kirkwood, Betty R., Hurt, Lisa, Amenga-Etego, Seeba, Tawiah, Charlotte, Zandoh, Charles, Danso, Samuel, Hurt, Chris, Edmond, Karen, Hill, Zelee, Ten Asbroek, Guus, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona and Arthur, Paul 2010. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVita): A cluster-randomized, placebo-controlled trial. Obstetrical & Gynecological Survey 65 (9) , pp. 552-554. 10.1097/OGX.0b013e3182021d40

Kirkwood, Betty R., Hurt, Lisa, Amenga-Etego, Seeba, Tawiah, Charlotte, Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas, Edmond, Karen, Hill, Zelee, ten Asbroek, Guus, Fenty, Justin, Owusu-Agyei, Seth, Campbell, Oona and Arthur, Paul 2010. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. The Lancet 375 (9726) , pp. 1640-1649. 10.1016/S0140-6736(10)60311-X

Gwynne, Sarah, Wills, Lauren, Joseph, Giannina, John, G., Staffurth, John Nicholas, Hurt, Chris Nicholas and Mukherjee, Saptarshi 2009. Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer1. Clinical Oncology 21 (9) , pp. 713-719. 10.1016/j.clon.2009.07.015

Edmond, Karen M., Quigley, Maria A., Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas, Agyei, Seth Owusu and Kirkwood, Betty R. 2008. Diagnostic accuracy of verbal autopsies in ascertaining the causes of stillbirths and neonatal deaths in rural Ghana. Paediatric and Perinatal Epidemiology 22 (5) , pp. 417-429. 10.1111/j.1365-3016.2008.00962.x

Edmond, Karen M., Quigley, Maria A., Zandoh, Charles, Danso, Samuel, Hurt, Chris Nicholas, Agyei, Seth Owusu and Kirkwood, Betty R. 2008. Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries. Paediatric and Perinatal Epidemiology 22 (5) , pp. 430-437. 10.1111/j.1365-3016.2008.00961.x

Patkar, V, Hurt, Christopher, Steele, R, Love, S, Purushotham, A, Williams, M, Thomson, R and Fox, J 2006. Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer. British Journal of Cancer 95 (11) , pp. 1490-1469. 10.1038/sj.bjc.6603470

Bury, Jonathan, Hurt, Christopher Nicholas, Roy, Anindita, Cheesman, Louise, Bradburn, Mike, Cross, Simon, Fox, John and Saha, Vaskar 2005. LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia. British Journal of Haematology 129 (6) , pp. 746-754. 10.1111/j.1365-2141.2005.05541.x

Fox, J., Alabassi, A., Black, E., Hurt, Chris Nicholas and Rose, T. 2004. Modelling clinical goals: a corpus of examples and a tentative ontology. In: Kaiser, Katharina, Miksch, Silvia and Tu, Samson W. eds. Computer-based Support for Clinical Guidelines and Protocols, Vol. 101. Studies in Health Technology and Informatics, IOS Press, pp. 31-45. (10.3233/978-1-60750-944-8-31)

Bury, J., Hurt, Chris Nicholas, Roy, A., Bradburn, M., Cross, S., Fox, J. and Saha, V. 2004. A quantitative and qualitative evaluation of LISA, a decision support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia. In: Fieschi, M., Coiera, E. and Yu-Chan, J. L. eds. MEDINFO 2004, Vol. 107. Studies in Health Technology and Informatics, IOS Press, pp. 197-201. (10.3233/978-1-60750-949-3-197)

Hurt, Chris Nicholas, Fox, J., Bury, J. and Saha, V. 2004. Computerised advice on drug dosage decisions in childhood leukaemia: a method and a safety strategy. Lecture Notes in Computer Science 2780 , pp. 158-162. 10.1007/978-3-540-39907-0_22

Jarup, L., Briggs, D., de Hoogh, C., Morris, S., Hurt, Christopher Nicholas, Lewin, A., Maitland, I., Richardson, S., Wakefield, J. and Elliott, P. 2002. Cancer risks in populations living near landfill sites in Great Britain. British Journal of Cancer 86 (11) , pp. 1732-1736. 10.1038/sj.bjc.6600311

Elliott, P., Briggs, D., Morris, S., de Hoogh, C., Hurt, Christopher Nicholas, Jensen, T. K., Maitland, I., Richardson, S., Wakefield, J. and Jarup, L. 2001. Risk of adverse birth outcomes in populations living near landfill sites. British Medical Journal (BMJ) 323 (7309) , pp. 363-368. 10.1136/bmj.323.7309.363

de Hoogh, C., Briggs, D. J., Hurt, Christopher Nicholas, Jarup, L. and Elliott, P. 2001. Modelling exposures from landfill sites: Methods and issues. Epidemiology 12 (4) , S42.

Jarup, L., Briggs, D., deHoogh, C., Hurt, Christopher Nicholas, Koid-Jensen, T., Morris, S., Wakefield, J. and Elliott, P. 2001. Health outcomes in populations living close to landfill sites. Epidemiology 12 (4) , S25.

This list was generated on Mon Sep 23 04:29:32 2019 BST.